These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3103686)

  • 1. Tissue-type plasminogen activator and urokinase: differences in the reaction pattern with the active-site titrant 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.
    Geiger M; Binder BR
    Biochim Biophys Acta; 1987 Mar; 912(1):34-40. PubMed ID: 3103686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of tissue-type plasminogen activator with 4-methylumbelliferyl-p-guanidinobenzoate hydrochloride.
    Urano T; Urano S; Castellino FJ
    Biochem Biophys Res Commun; 1988 Jan; 150(1):45-51. PubMed ID: 3122757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    J Biol Chem; 1991 Mar; 266(7):4041-4. PubMed ID: 1900284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of soluble tissue factor on the kinetic mechanism of factor VIIa: enhancement of p-guanidinobenzoate substrate hydrolysis.
    Payne MA; Neuenschwander PF; Johnson AE; Morrissey JH
    Biochemistry; 1996 Jun; 35(22):7100-6. PubMed ID: 8679536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of a new fluorogenic active-site titrant of serine proteases.
    Livingston DC; Brocklehurst JR; Cannon JF; Leytus SP; Wehrly JA; Peltz SW; Peltz GA; Mangel WF
    Biochemistry; 1981 Jul; 20(15):4298-306. PubMed ID: 6456760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serine protease activity of human serum albumin towards 4-methylumbelliferyl-guanidinobenzoate (MUGB) and diisopropyl fluorophosphate (DEP): implications for the use of MUGB reactivity in amniotic fluid in prenatal diagnosis of cystic fibrosis.
    Schwartz M
    Clin Chim Acta; 1982 Sep; 124(2):213-23. PubMed ID: 6754141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the major 4-methylumbelliferyl p-guanidinobenzoate-hydrolyzing plasma protein in cystic fibrosis: implication for intrauterine and heterozygote detection.
    Branchini BR; Salituro GM; Rosenstein BJ
    Pediatr Res; 1983 Nov; 17(11):850-5. PubMed ID: 6646895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    Biochim Biophys Acta; 1986 Dec; 884(3):402-8. PubMed ID: 3778931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential reactivity of Glu-Gly-Arg-CH2Cl, a synthetic urokinase inhibitor, with single-chain and two-chain forms of urokinase-type plasminogen activator.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1987 Jan; 162(2):351-6. PubMed ID: 3803392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the mouse sperm plasma membrane zona-binding site sensitive to trypsin inhibitors.
    Benau DA; Storey BT
    Biol Reprod; 1987 Mar; 36(2):282-92. PubMed ID: 3580450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system.
    Yarzábal A; Avilán L; Hoelzl K; de Muñoz M; Puig J; Kansau I
    Braz J Med Biol Res; 2000 Sep; 33(9):1015-21. PubMed ID: 10973131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
    Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.
    Korner G; Bjornsson TD; Vlodavsky I
    J Cell Physiol; 1993 Mar; 154(3):456-65. PubMed ID: 8436596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directing sequence-specific proteolysis to new targets. The influence of loop size and target sequence on selective proteolysis by tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Coombs GS; Bergstrom RC; Madison EL; Corey DR
    J Biol Chem; 1998 Feb; 273(8):4323-8. PubMed ID: 9468480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.